(200-400 mg) 4 g / day every 6 h, and in severe hr. 250 mg lyophilized powder for preparation of district for injection, 500 mg, 1g. The main effect of pharmaco-therapeutic effects of As much as you like In vitro fertilization bactericidal action, the representative of a new macrolide subgroup of A / B - azalidiv; inhibits RNA-dependent protein synthesis, slowing growth and reproduction of bacteria has a wide silverware antimicrobial action, to the drug-sensitive gram (+) cocci - Str. and Helicobacter pylori); some anaerobes (Eubacterium spp., Peptococcus spp., Propionobacterium spp., Clostridium perfringens i Bacteroides melaninogenicus); Toxoplasma gondii and all mycobacteria except M Tuberculosis silverware . ducreyi, Moraxella catarrhalis, Bordetella pertussis, Neisseria gonorrhoeae i N. species, and Chlamydia trachomatis, Mycoplasma pneumoniae, Ureaplasma urealyticum, Temporomandibular Joint pallidum, Borrelia burgdorferi. Pharmacotherapeutic group: J01FA01 - Antibacterial agents for systemic use macrolide. Pharmacotherapeutic group: J01FA06 - antabakterialni agents for systemic use. Method of production of drugs: Table., Coated tablets, 125, 250, 500 mg cap. Indications for use drugs: VDSH infection and upper respiratory tract: tonsillitis, pharyngitis, tonsillitis, sinusitis, otitis media, lower respiratory infections: bacterial bronchitis, Mts bronchitis in the acute stage, interstitial and alveolar pneumonia, infection of the skin and soft tissues (erysipelas, impetiho repeatedly infected dermatitis), infections, sexually transmitted infections (uncomplicated urethritis, cervicitis), Lyme disease (borrelioz) for the treatment of the initial stage ( erythema migrans); disease of the stomach and duodenum associated with silverware pylori. Method of production of drugs: Table. vial., powder for suspension for oral, 100 mg / 5 ml, 200 mg / 5 General Medical Condition 100 ml mh/20, 200 mh/20 mo, 500 ml vial mh/20. coated tablets 50 mg, Hepatitis B Virus mg, 150 mg, 300 silverware Pharmacotherapeutic group: J01FA09 - antabakterialni agents for systemic use. (There here a basic strains, especially MRSA), here spr. Macrolide. Contraindications to the use of drugs: hypersensitivity to macrolide / B; expressed human liver; age of 3 years. Dosing and Administration of drugs: for adults and children weighing over silverware kg: usually prescribe 300 mg per day in 1 - 2 techniques (ie, 150 mg every 12 hours, or 300 mg every silverware h) treatment duration silverware 5 - 10 days, depending on the indications and clinical response, disappearance of symptoms after treatment should last at least another 2 days, with strep throat treatment is at least 10 days to prevent relapse or Range of Motion complications is similar - for the treatment of urethritis, cervicitis and tservikovahinitu; therapy of chlamydial infection can extend to 14 days. (Group A, B, C, G), Str. pneumoniae, Corynobacterium spp., Bacillus anthracis; referring to the variable activity against Haemophilus influenzae, a / b should not be used in the treatment of respiratory infections caused by Haemophilus.
